Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institu... von Garcia-Aguilar, Julio, Prof, Renfro, Lindsay A, PhD, Chow, Oliver S, MD, Shi, Qian, PhD, Carrero, Xiomara W, BBA, Lynn, Patricio B, MD, Thomas, Charles R, Prof, Chan, Emily, MD, Cataldo, Peter A, Prof, Marcet, Jorge E, Prof, Medich, David S, MD, Johnson, Craig S, MD, Oommen, Samuel C, MD, Wolff, Bruce G, Prof, Pigazzi, Alessio, MD, McNevin, Shane M, MD, Pons, Roger K, MD, Bleday, Ronald, Prof

Volltext

Bayesian Response Adaptive Randomization for Randomized Clinical Trials With Continuous Outcomes: The Role of Covariate Adjustment von Aslanyan, Vahan, Pickering, Trevor, Nuño, Michelle, Renfro, Lindsay A, Pa, Judy, Mack, Wendy J

Volltext

ACCENT-Based Web Calculators to Predict Recurrence and Overall Survival in Stage III Colon Cancer von RENFRO, Lindsay A, GROTHEY, Axel, YOTHERS, Greg, SARGENT, Daniel J, YUAN XUE, SALTZ, Leonard B, ANDRE, Thierry, TWELVES, Chris, LABIANCA, Roberto, ALLEGRA, Carmen J, ALBERTS, Steven R, LOPRINZI, Charles L

Volltext

Surrogate End Points in Soft Tissue Sarcoma: Methodologic Challenges von Renfro, Lindsay A, Shi, Qian, Sargent, Daniel J

Volltext

Prospective Multicenter Study of the Impact of Oncotype DX Colon Cancer Assay Results on Treatment Recommendations in Stage II Colon Cancer Patients von Srivastava, Geetika, Renfro, Lindsay A., Behrens, Robert J., Lopatin, Margarita, Chao, Calvin, Soori, Gamini S., Dakhil, Shaker R., Mowat, Rex B., Kuebler, J. Philip, Kim, George, Mazurczak, Miroslaw, Lee, Mark, Alberts, Steven R.

Volltext

Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer von Foster, Nathan R., Renfro, Lindsay A., Schild, Steven E., Redman, Mary W., Wang, Xiaofei F., Dahlberg, Suzanne E., Ding, Keyue, Bradbury, Penelope A., Ramalingam, Suresh S., Gandara, David R., Shibata, Taro, Saijo, Nagahiro, Vokes, Everett E., Adjei, Alex A., Mandrekar, Sumithra J.

Volltext

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer von Grothey, Axel, Sobrero, Alberto F, Shields, Anthony F, Yoshino, Takayuki, Paul, James, Taieb, Julien, Souglakos, John, Shi, Qian, Kerr, Rachel, Labianca, Roberto, Meyerhardt, Jeffrey A, Vernerey, Dewi, Yamanaka, Takeharu, Boukovinas, Ioannis, Meyers, Jeffrey P, Renfro, Lindsay A, Niedzwiecki, Donna, Watanabe, Toshiaki, Torri, Valter, Saunders, Mark, Sargent, Daniel J, Andre, Thierry, Iveson, Timothy

Volltext

Bayesian adjusted R2 for the meta-analytic evaluation of surrogate time-to-event endpoints in clinical trials von Renfro, Lindsay A., Shi, Qian, Sargent, Daniel J., Carlin, Bradley P.

Volltext

Prospective Evaluation of a 12-gene assay on patient treatment decisions and physician confidence in mismatch repair proficient stage IIA colon cancer von Renfro, Lindsay A, Zhang, Nan, Lopatin, Margarita, Chao, Calvin, Alberts, Steven R

Volltext

Non-V600 BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer von Jones, Jeremy C, Renfro, Lindsay A, Al-Shamsi, Humaid O, Schrock, Alexa B, Rankin, Andrew, Zhang, Ben Y, Kasi, Pashtoon M, Voss, Jesse S, Leal, Alexis D, Sun, James, Ross, Jeffrey, Ali, Siraj M, Hubbard, Joleen M, Kipp, Benjamin R, McWilliams, Robert R, Kopetz, Scott, Wolff, Robert A, Grothey, Axel

Volltext

Bayesian adaptive trial design for a continuous biomarker with possibly nonlinear or nonmonotone prognostic or predictive effects von Liu, Yusha, Kairalla, John A., Renfro, Lindsay A.

Volltext

Latest Developments in “Adaptive Enrichment” Clinical Trial Designs in Oncology von Tu, Yue, Renfro, Lindsay A.

Volltext

Center-within-trial versus trial-level evaluation of surrogate endpoints von Renfro, Lindsay A., Shi, Qian, Xue, Yuan, Li, Junlong, Shang, Hongwei, Sargent, Daniel J.

Volltext

Precision oncology: A new era of cancer clinical trials von Renfro, Lindsay A, An, Ming-Wen, Mandrekar, Sumithra J

Volltext

Germline variation in colorectal risk Loci does not influence treatment effect or survival in metastatic colorectal cancer von Sanoff, Hanna K, Renfro, Lindsay A, Poonnen, Pradeep, Ambadwar, Pratibha, Sargent, Daniel J, Goldberg, Richard M, McLeod, Howard

Volltext

Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Col... von Shah, Manish A, Renfro, Lindsay A, Allegra, Carmen J, André, Thierry, de Gramont, Aimery, Schmoll, Hans-Joachim, Haller, Daniel G, Alberts, Steven R, Yothers, Greg, Sargent, Daniel J

Volltext

Findings from the Adjuvant Colon Cancer End Points (ACCENT) Collaborative Group: the power of pooled individual patient data from multiple clinical trials von Renfro, Lindsay A., Sargent, Daniel J.

Volltext

Comparative Economics of a 12-Gene Assay for Predicting Risk of Recurrence in Stage II Colon Cancer von Alberts, Steven R., Yu, Tiffany M., Behrens, Robert J., Renfro, Lindsay A., Srivastava, Geetika, Soori, Gamini S., Dakhil, Shaker R., Mowat, Rex B., Kuebler, John P., Kim, George P., Mazurczak, Miroslaw A., Hornberger, John

Volltext

Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533 von Madanat-Harjuoja, Laura M, Renfro, Lindsay A, Klega, Kelly, Tornwall, Brett, Thorner, Aaron R, Nag, Anwesha, Dix, David, Dome, Jeffrey S, Diller, Lisa R, Fernandez, Conrad V, Mullen, Elizabeth A, Crompton, Brian D

Volltext

Association of age with survival in patients with metastatic colorectal cancer: analysis from the ARCAD Clinical Trials Program von Lieu, Christopher H, Renfro, Lindsay A, de Gramont, Aimery, Meyers, Jeffrey P, Maughan, Timothy S, Seymour, Matthew T, Saltz, Leonard, Goldberg, Richard M, Sargent, Daniel J, Eckhardt, S Gail, Eng, Cathy

Volltext